Lactoferrin (LF) is an iron binding protein, which may represent a tar
get for antineutrophil cytoplasmic antibodies (ANCA) in patients affec
ted by rheumatoid arthritis, ulcerative colitis, and primary sclerosin
g cholangitis, Here we describe the production and characterization of
two new monoclonal antibodies (MAbs) against human LF, These MAbs (AG
M 10.14, an IgG(1), and AGM 2.29, an IgG(2b)) recognize spatially dist
ant epitopes of LF as assessed by cross-blocking experiments, We also
demonstrated by indirect immunofluorescence that both MAbs react with
ethanol-fixed neutrophil granulocytes showing a perinuclear staining p
attern, AGM 2.29 and AGM 10.14 have been utilized as capture and label
ed tracer antibody, respectively, in a double determinant immunoassay
(DDIA) to measure soluble LF, The results obtained show that this DDIA
allows us to quantify even low concentrations of LF, the maximal rang
e of the assay sensitivity being between 12 and 780 ng/ml, Therefore,
AGM 10.14 and AGM 2.29 may represent useful reagents for studying the
role of autoantibodies to LF as well as for measuring soluble LF, whic
h is a reliable secretory marker of neutrophil activation.